Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Borosil Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
Borosil Q4 FY26 quarterly results analysis. - Borosil Limited is confident about future growth driven by market shifts towards glassware, healthier options, and stainless steel products. Market Cap ₹2,900, P/E 37.3. AI-powered earnings insights.
5 Aug 2026
Borosil Q2 FY26 Results — Earnings Call Analysis
Q2 FY26
Borosil Q2 FY26 quarterly results analysis. - Management targets a medium-term revenue CAGR of 15% to 20%, maintaining bullish outlook despite recent muted demand. Market Cap ₹2,900, P/E 37.3. AI-powered earnings insights.
5 Aug 2026
Borosil Q1 FY26 Results — Earnings Call Analysis
Q1 FY26
Borosil Q1 FY26 quarterly results analysis. - Borosil aims to return to a growth path next year with a year-on-year growth target of 15% to 20%. Market Cap ₹2,900, P/E 37.3. AI-powered earnings insights.
5 Aug 2026
Max Healthcare Q3 FY26 Results — Earnings Call Analysis
Q3 FY26
Max Healthcare Q3 FY26 quarterly results analysis. - Network gross revenue grew 24% YoY to INR 5,266 crore in the recent quarter, indicating strong ongoing growth. Market Cap ₹105,897, P/E 71.4. AI-powered earnings insights.
5 Aug 2026
Max Healthcare Q2 FY26 Results — Earnings Call Analysis
Q2 FY26
Max Healthcare Q2 FY26 quarterly results analysis. - Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations. - Existing units showed a 16% revenue growth, with like-for-like ARPOB growth of 5% year-on-year. - Occupancy in base hospitals
5 Aug 2026
Max Healthcare Q1 FY26 Results — Earnings Call Analysis
Q1 FY26
Max Healthcare Q1 FY26 quarterly results analysis. - Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions). Market Cap ₹105,897, P/E 71.4. AI-powered earnings insights.
5 Aug 2026
Rossari Biotech Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
Rossari Biotech Q4 FY26 quarterly results analysis. - Export growth expected to continue outperforming domestic growth, though at a moderated pace compared to the 26% YoY seen in 9M FY26. Market Cap ₹2,903, P/E 19.3. AI-powered earnings insights.
5 Aug 2026
Mindspace Busine Q2 FY26 Results — Earnings Call Analysis
Q2 FY26
Mindspace Busine Q2 FY26 quarterly results analysis. - Mindspace REIT delivered strong Q1 FY'26 results with 24.2% YoY NOI growth and 21.4% revenue growth. Market Cap ₹32,592, P/E 48.2. AI-powered earnings insights.
5 Aug 2026
Mindspace Busine Q4 FY25 Results — Earnings Call Analysis
Q4 FY25
Mindspace Busine Q4 FY25 quarterly results analysis. - The acquisition of Commerzone Raidurg, a top-class asset in prime CBD Madhapur, Hyderabad, is expected to add significant value and growth to Mindspace REIT's portfolio. - The acquisition adds Rs. Market Cap ₹32,592, P/E 48.2. AI-powered earnings insights.
5 Aug 2026
Rossari Biotech Q3 FY26 Results — Earnings Call Analysis
Q3 FY26
Rossari Biotech Q3 FY26 quarterly results analysis. - Revenue growth in Q2 FY26 was strong at 18% YoY, driven largely by volume increases across all verticals (HPPC, TSC, AHN). - Exports grew robustly by 36% YoY in Q2 and 27% in H1, now comprising nearly 28% of total revenue, with growth driven by new geographies like
5 Aug 2026
Rossari Biotech Q2 FY26 Results — Earnings Call Analysis
Q2 FY26
Rossari Biotech Q2 FY26 quarterly results analysis. - Rossari Biotech expects mid-double-digit revenue growth of around 14%-15% annually over the next 2 years. Market Cap ₹2,903, P/E 19.3. AI-powered earnings insights.
5 Aug 2026
Rossari Biotech Q1 FY26 Results — Earnings Call Analysis
Q1 FY26
Rossari Biotech Q1 FY26 quarterly results analysis. - Rossari Biotech targets mid-teens percentage growth in overall business revenue, with an annual growth rate around 15% (Page 4, 6). - Ethoxylation capacity expansion expected to be commissioned by Q2 FY26, supporting growth in key segments (Page 4). - HPPC (Home and
5 Aug 2026
Altius Telecom Q3 FY26 Results — Earnings Call Analysis
Q3 FY26
Altius Telecom Q3 FY26 quarterly results analysis. - Revenue and EBITDA CAGR expected to be in the range of 4% to 7%, driven by both tower additions and tenancy growth. Market Cap ₹52,114, P/E 48.7. AI-powered earnings insights.
5 Aug 2026
Cohance Life Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
Cohance Life Q4 FY26 quarterly results analysis. - Management remains committed to the USD 1 billion sales target by FY '30, though timing may shift slightly due to current challenges. Market Cap ₹16,418, P/E 152.5. AI-powered earnings insights.
5 Aug 2026
Prince Pipes Q2 FY26 Results — Earnings Call Analysis
Q2 FY26
Prince Pipes Q2 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹3,034, P/E 29.1. AI-powered earnings insights.
5 Aug 2026
Prince Pipes Q1 FY26 Results — Earnings Call Analysis
Q1 FY26
Prince Pipes Q1 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹3,034, P/E 29.1. AI-powered earnings insights.
5 Aug 2026
Ujjivan Small Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
Ujjivan Small Q4 FY26 quarterly results analysis. - Ujjivan Small Finance Bank expects acceleration in asset growth going forward, driven by both microfinance and secured loan segments. Market Cap ₹13,584, P/E 15.0. AI-powered earnings insights.
5 Aug 2026
Hitachi Energy Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
Hitachi Energy Q4 FY26 quarterly results analysis. - The domestic market outlook for FY '27 is very strong, driven by transmission, electrification, and data center growth. - Data centers are expected to be a significant growth opportunity, with evolving AI-ready data centers demanding flexible, high-capacity power sys
5 Aug 2026
Hitachi Energy Q4 FY25 Results — Earnings Call Analysis
Q4 FY25
Hitachi Energy Q4 FY25 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹143,965, P/E 140.0. AI-powered earnings insights.
5 Aug 2026
SBI Cards Q4 FY26 Results — Earnings Call Analysis
Q4 FY26
SBI Cards Q4 FY26 quarterly results analysis. - SBI Card aims to scale up its business in a calibrated manner for stronger, sustainable, and profitable long-term growth. Market Cap ₹62,992, P/E 27.7. AI-powered earnings insights.
5 Aug 2026
